What is a stock summary page? Click here for an overview.
Business Description
BCAL Diagnostics Ltd
ISIN : AU0000160921
Share Class Description:
ASX:BDX: Ordinary SharesDescription
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.38 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -0.19 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.8 | |||||
| 9-Day RSI | 54 | |||||
| 14-Day RSI | 52.56 | |||||
| 3-1 Month Momentum % | 1.01 | |||||
| 6-1 Month Momentum % | -28.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.54 | |||||
| Quick Ratio | 6.54 | |||||
| Cash Ratio | 5.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -28.61 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -100.23 | |||||
| ROA % | -74.76 | |||||
| ROIC % | -314.78 | |||||
| ROC (Joel Greenblatt) % | -245.58 | |||||
| ROCE % | -88.45 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.2 | |||||
| Price-to-Tangible-Book | 3.5 | |||||
| EV-to-EBIT | -4.11 | |||||
| EV-to-EBITDA | -4.65 | |||||
| EV-to-FCF | -4.05 | |||||
| Price-to-Net-Current-Asset-Value | 5.25 | |||||
| Price-to-Net-Cash | 10.5 | |||||
| Earnings Yield (Greenblatt) % | -24.33 | |||||
| FCF Yield % | -21.01 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BCAL Diagnostics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.027 | ||
| Beta | 0.6 | ||
| 3-Year Sharpe Ratio | 0.11 | ||
| 3-Year Sortino Ratio | 0.24 | ||
| Volatility % | 101.14 | ||
| 14-Day RSI | 52.56 | ||
| 14-Day ATR (A$) | 0.005491 | ||
| 20-Day SMA (A$) | 0.100625 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (A$) | 0.086 - 0.185 | ||
| Shares Outstanding (Mil) | 365.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BCAL Diagnostics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BCAL Diagnostics Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
BCAL Diagnostics Ltd Frequently Asked Questions
What is BCAL Diagnostics Ltd(ASX:BDX)'s stock price today?
The current price of ASX:BDX is A$0.11. The 52 week high of ASX:BDX is A$0.19 and 52 week low is A$0.09.
When is next earnings date of BCAL Diagnostics Ltd(ASX:BDX)?
The next earnings date of BCAL Diagnostics Ltd(ASX:BDX) is .
Does BCAL Diagnostics Ltd(ASX:BDX) pay dividends? If so, how much?
BCAL Diagnostics Ltd(ASX:BDX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers